Gregory H. Bailey - 14 Aug 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Reporting relationship: Director
Issuer ticker: SER
Reported as of: 14 Aug 2024
Net transaction value: +$45,228
SEC form: 4
Accepted by SEC: 16 Aug 2024, 16:20:15 UTC
Prior SEC filing: 31 May 2024
Next SEC filing: 20 Aug 2024
Source filing: View source filing
Reporting owner signature: /s/ Gregory Bailey

Key filing fact

Gregory H. Bailey filed Form 4 for Serina Therapeutics, Inc. (SER) on 16 Aug 2024.

Key facts

This page summarizes Gregory H. Bailey's Form 4 filing for Serina Therapeutics, Inc. (SER).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Aug 2024, 16:20.

Change

Previous filing in this sequence was filed on 31 May 2024.
Current net transaction value: +$45,228.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SER transaction

Common Stock

Purchase

Transaction value: $45,228
Shares: +6,400
Change %: +32%
Price: $7.07
Shares after: 26,606
Date: 14 Aug 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reflects the weighted average purchase price of multiple transactions ranging from a low of $6.83 per share to a high of $7.35 per share. Upon the written request of the SEC, the issuer or a security holder of the issuer, the reporting person agrees to provide the number of shares sold at each sale price.